Cargando…

Immune mediated therapy and MEK inhibition: preclinical assessment of immunobiology and combination activity in vitro and in vivo

Detalles Bibliográficos
Autores principales:	Stewart, Ross, Poon, Edmund, Mullins, Stefanie, Watkins, Amanda, Smith, Paul D, Wilkinson, Robert W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288435/ http://dx.doi.org/10.1186/2051-1426-2-S3-P128

Ejemplares similares

A mouse GITRl fusion protein drives T cell activation and antitumor activity in preclinical mouse models of cancer
por: Leyland, Rebecca, et al.
Publicado: (2015)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment
por: Poon, Edmund, et al.
Publicado: (2017)

Preclinical animal models of COPD
por: Vlahos, Ross
Publicado: (2013)

The prediction of the allergenicity food proteins by combining an in vitro and an in vivo model
por: Van Bilsen, Jolanda, et al.
Publicado: (2015)

MEK inhibition, alone or in combination with BRAF inhibition, impairs multiple functions of isolated normal human lymphocytes and dendritic cells
por: Vella, Laura J, et al.
Publicado: (2013)

Preclinical efficacy of belinostat in combination with zidovudine in adult T-cell leukemia-lymphoma
por: Toomey, Ngoc, et al.
Publicado: (2015)

Phase Ib/II, open-label, dose-escalation study of LGX818, an oral selective BRAF inhibitor, in combination with MEK162, an oral MEK1/2 inhibitor, in patients with BRAF V600-dependent advanced solid tumors: preliminary results
por: Kefford, Richard, et al.
Publicado: (2014)

Preclinical evaluation of MVA-MUC1-IL2 in combination with chemotherapy in murine models
por: De Meyer, Micaël, et al.
Publicado: (2013)

BRAFV600E mutation positive metastatic melanoma in a young woman treated with anti-BRAF/anti MEK combination: a case report
por: Giovannoni, Sara, et al.
Publicado: (2015)

PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer
por: Hay, T, et al.
Publicado: (2008)

Immunobiology of reproduction
Publicado: (1994)

Mitogens in Immunobiology
por: Kierszenbaum, F.
Publicado: (1977)

Immunobiology of cholangiocarcinoma
por: Loeuillard, Emilien, et al.
Publicado: (2019)

Immunobiologicals in dermatology()
por: Silva, Dimitri Luz Felipe da, et al.
Publicado: (2022)

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
por: Caputo, Emilia, et al.
Publicado: (2015)

Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer
por: Foy, Susan P, et al.
Publicado: (2014)

P11-02. In situ analysis by confocal microscopy of the cellular components of mucosal tissues within the framework of preclinical vaccine studies
por: Boggiano, CA, et al.
Publicado: (2009)

HIV-1 selectively exploits cross-reactive CTL “help” to promote dysfunctional programming of pro-inflammatory dendritic cells
por: Mailliard, RB, et al.
Publicado: (2012)

In vivo and in vitro role of cholecystokinin in nitric oxide
por: Saia, R Simone, et al.
Publicado: (2010)

Immunobiology : the immune system in health and disease
Publicado: (2001)

In vitro, in vivo and microscopic analysis of tumor immunotherapy using combination of two antibodies against the same ErbB2 target
por: Toth, Gabor, et al.
Publicado: (2014)

Combination of EP4 antagonist and checkpoint inhibitors promotes anti-tumor effector T cells in preclinical tumor models
por: Bao, Xingfeng, et al.
Publicado: (2015)

Dichloroacetate is an effective treatment for sarcoma models in vitro and in vivo
por: Rooke, Melissa, et al.
Publicado: (2014)

S7. KEYNOTE LECTURE: Immunobiological properties of the human cancer stem cells
por: Maccalli, C, et al.
Publicado: (2014)

Novel immunobiologics for psoriasis
por: Ghosh, Nilanjan, et al.
Publicado: (2008)

Immunobiology of visceral leishmaniasis
por: Kumar, Rajiv, et al.
Publicado: (2012)

CD2 Immunobiology
por: Binder, Christian, et al.
Publicado: (2020)

Immunobiology of Acute Chorioamnionitis
por: Cappelletti, Monica, et al.
Publicado: (2020)

Immunobiology of Cervix Ripening
por: Yellon, Steven M.
Publicado: (2020)

The Immunobiology of Nipah Virus
por: Liew, Yvonne Jing Mei, et al.
Publicado: (2022)

Synergistic effects of cytotoxic drugs and antiresorptive agents in vitro and in vivo
por: Ottewell, PD, et al.
Publicado: (2006)

Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2013)

Immune combinational therapy targeting OX40 and IDO synergistically enhances efficacy of a cancer vaccine
por: Berrong, Zuzana, et al.
Publicado: (2014)

Cyclophosphamide mechanism of action in preclinical tecemotide studies
por: Hance, Ken, et al.
Publicado: (2013)

Lost in translation? Bridging the preclinical / clinical divide
por: Baker, Mark, et al.
Publicado: (2012)

Immunobiology; current knowledge of basic concepts in immunology and their clinical applications
por: Good, Robert A., 1922-2003
Publicado: (1971)

The thymus in immunobiology : structure, function, and role in disease /
Publicado: (1964)

Advancements in preclinical screening methods for artemisinins during pregnancy
por: Donegan, G, et al.
Publicado: (2010)

Preclinical to clinical translation of anti-PD-1 blockade
por: Hirsch, Heather, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_atvm7nv684e6qo73nlq2n17lu4